Dr. Reddy's Laboratories Limited FII & DII Activity

FII Net (₹ Cr)

+871.83Buy 16,834.53Sell 15,962.7

DII Net (₹ Cr)

+643.35Buy 17,240.9Sell 16,597.55

FII F&O Net (contracts)

+643395Index + stock futures

5-Day Flow Trend

Date	FII Net (₹ Cr)	DII Net (₹ Cr)
2026-10-28	+871.83	+643.35
2026-10-27	−1462.49	+2609.57
2026-10-26	−1462.49	+2609.57
2026-10-23	+887.65	+3235.36
2026-10-22	−3458.70	+2891.32

AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

On October 28 2026, foreign institutional investors (FII) posted a net cash inflow of ₹ 871.83 crore into Indian equities, while domestic institutional investors (DII) added ₹ 643.35 crore in cash purchases. The combined net cash influx of ₹ 1,515.18 crore indicates a broadly supportive buying environment for the market. No block or bulk trades were recorded for Dr. Reddy’s Laboratories Limited (DRREDDY) during the session.

Trend vs 5‑Day Average

The day’s cash inflow from FIIs reverses the recent five‑day average of ₹ ‑894.74 crore, turning a prior net outflow into a sizeable purchase. Conversely, DII cash buying remains consistent with the five‑day average of ₹ 2,592.03 crore, staying comfortably inside the usual range of domestic buying pressure.

F&O Positioning Data

FIIs expanded their futures‑and‑options exposure by ₹ 643,395 crore, reflecting heightened speculative or hedging activity across the derivatives market. Their index‑futures stance shows a long‑to‑short ratio of 1.2, indicating a modest net bias toward bullish positions.

Healthcare Sector Flow

The healthcare sector, where DRREDDY operates, has experienced a net inflow from FIIs and a continued strengthening from DIIs over the past week, reinforcing the theme of sectoral optimism.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-10-28

Same Sector

ALKEMAlkem Laboratories LimitedNeutral APOLLOHOSPApollo Hospitals Enterprise LimitedNeutral AUROPHARMAAurobindo Pharma LimitedNeutral BIOCONBiocon LimitedNeutral CIPLACipla LimitedNeutral

Frequently Asked Questions

What is FII net buying/selling in Dr. Reddy's Laboratories Limited today?

FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹871.83 Cr (net buying) as of 2026-10-28. This market-wide figure applies to all F&O stocks including Dr. Reddy's Laboratories Limited.

What is DII activity in Dr. Reddy's Laboratories Limited today?

DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹643.35 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.

What is FII F&O net for Dr. Reddy's Laboratories Limited today?

FII net F&O position (index + stock futures combined) is +6,43,395 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.

Were there any block deals in Dr. Reddy's Laboratories Limited?

Block deal data for Dr. Reddy's Laboratories Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.

How does FII/DII data affect Dr. Reddy's Laboratories Limited stock price?

FII and DII flows are market-wide data — all F&O stocks including Dr. Reddy's Laboratories Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Dr. Reddy's Laboratories Limited's individual OI buildup type, this provides a directional framework.